These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 22253220)
1. ID2: A negative transcription factor regulating oligodendroglia differentiation. Chen XS; Zhang YH; Cai QY; Yao ZX J Neurosci Res; 2012 May; 90(5):925-32. PubMed ID: 22253220 [TBL] [Abstract][Full Text] [Related]
2. Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation. Samanta J; Kessler JA Development; 2004 Sep; 131(17):4131-42. PubMed ID: 15280210 [TBL] [Abstract][Full Text] [Related]
3. Could the inhibitor of DNA binding 2 and 4 play a role in white matter injury? Gou X; Tang Y; Qu Y; Xiao D; Ying J; Mu D Rev Neurosci; 2019 Jul; 30(6):625-638. PubMed ID: 30738015 [TBL] [Abstract][Full Text] [Related]
4. Regulation of Olig2 during astroglial differentiation in the subventricular zone of a cuprizone-induced demyelination mouse model. Chen LP; Li ZF; Ping M; Li R; Liu J; Xie XH; Song XJ; Guo L Neuroscience; 2012 Sep; 221():96-107. PubMed ID: 22771621 [TBL] [Abstract][Full Text] [Related]
5. Developmental changes and subcellular location in inhibitor of DNA binding 2 (Id2) immunoreactivity in the rat Corpus callosum. Chen XS; Chen XH; Ye JN; Cai QY; Zhan XL; Liu Z; Yao ZX Acta Histochem; 2012 Nov; 114(7):653-8. PubMed ID: 22172709 [TBL] [Abstract][Full Text] [Related]
6. The mechanistic target of rapamycin pathway downregulates bone morphogenetic protein signaling to promote oligodendrocyte differentiation. Ornelas IM; Khandker L; Wahl SE; Hashimoto H; Macklin WB; Wood TL Glia; 2020 Jun; 68(6):1274-1290. PubMed ID: 31904150 [TBL] [Abstract][Full Text] [Related]
7. The complex world of oligodendroglial differentiation inhibitors. Kremer D; Aktas O; Hartung HP; Küry P Ann Neurol; 2011 Apr; 69(4):602-18. PubMed ID: 21520230 [TBL] [Abstract][Full Text] [Related]
8. Olig gene function in CNS development and disease. Ligon KL; Fancy SP; Franklin RJ; Rowitch DH Glia; 2006 Jul; 54(1):1-10. PubMed ID: 16652341 [TBL] [Abstract][Full Text] [Related]
9. Id2 and Id4 are not the major negative regulators of oligodendrocyte differentiation during early central nervous system development. Huang H; Wu H; He W; Zhou F; Yu X; Yi M; Du J; Xie B; Qiu M Glia; 2022 Mar; 70(3):590-601. PubMed ID: 34889481 [TBL] [Abstract][Full Text] [Related]
10. Nuclear expression of S100B in oligodendrocyte progenitor cells correlates with differentiation toward the oligodendroglial lineage and modulates oligodendrocytes maturation. Deloulme JC; Raponi E; Gentil BJ; Bertacchi N; Marks A; Labourdette G; Baudier J Mol Cell Neurosci; 2004 Dec; 27(4):453-65. PubMed ID: 15555923 [TBL] [Abstract][Full Text] [Related]
11. Invivo insulin deficiency as a potential etiology for demyelinating disease. Gong X; Xie Z; Zuo H Med Hypotheses; 2008 Sep; 71(3):399-403. PubMed ID: 18621485 [TBL] [Abstract][Full Text] [Related]
12. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Lasorella A; Noseda M; Beyna M; Yokota Y; Iavarone A Nature; 2000 Oct; 407(6804):592-8. PubMed ID: 11034201 [TBL] [Abstract][Full Text] [Related]
13. DNA methylation regulates the expression of the negative transcriptional regulators ID2 and ID4 during OPC differentiation. Tiane A; Schepers M; Riemens R; Rombaut B; Vandormael P; Somers V; Prickaerts J; Hellings N; van den Hove D; Vanmierlo T Cell Mol Life Sci; 2021 Oct; 78(19-20):6631-6644. PubMed ID: 34482420 [TBL] [Abstract][Full Text] [Related]
14. Expression of Id2 in the developing limb is associated with zones of active BMP signaling and marks the regions of growth and differentiation of the developing digits. Lorda-Diez CI; Torre-Pérez N; García-Porrero JA; Hurle JM; Montero JA Int J Dev Biol; 2009; 53(8-10):1495-502. PubMed ID: 19247943 [TBL] [Abstract][Full Text] [Related]
15. Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC. Chen X; Zankl A; Niroomand F; Liu Z; Katus HA; Jahn L; Tiefenbacher C J Mol Cell Cardiol; 2006 Jul; 41(1):26-33. PubMed ID: 16716349 [TBL] [Abstract][Full Text] [Related]
16. Id2 mediates oligodendrocyte precursor cell maturation arrest and is tumorigenic in a PDGF-rich microenvironment. Havrda MC; Paolella BR; Ran C; Jering KS; Wray CM; Sullivan JM; Nailor A; Hitoshi Y; Israel MA Cancer Res; 2014 Mar; 74(6):1822-32. PubMed ID: 24425046 [TBL] [Abstract][Full Text] [Related]
17. Olig1 is downregulated in oligodendrocyte progenitor cell differentiation. Gong X; Lin T; Sun Z; Fu M; Zuo H; Xie Z Neuroreport; 2008 Aug; 19(12):1203-7. PubMed ID: 18628665 [TBL] [Abstract][Full Text] [Related]
18. The inhibitor of DNA binding 2 is mainly expressed in oligodendrocyte lineage cells in adult rat brain. Chen XS; Zhou DS; Yao ZX Neurosci Lett; 2007 Nov; 428(2-3):93-8. PubMed ID: 18029094 [TBL] [Abstract][Full Text] [Related]
19. Regulation of glioblastoma multiforme stem-like cells by inhibitor of DNA binding proteins and oligodendroglial lineage-associated transcription factors. Wu Y; Richard JP; Wang SD; Rath P; Laterra J; Xia S Cancer Sci; 2012 Jun; 103(6):1028-37. PubMed ID: 22380883 [TBL] [Abstract][Full Text] [Related]
20. Sending mixed signals: bone morphogenetic protein in myelination and demyelination. See JM; Grinspan JB J Neuropathol Exp Neurol; 2009 Jun; 68(6):595-604. PubMed ID: 19458544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]